BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

March/April Archive 2003 - have your press release here?

Hybrigenics acquires Semaia Merged companies will leverage proprietary tools to identify and validate oncology targets and develop drug candidates

Nonlinear Dynamics expands presence in North America with new distributor in Canada

FDA Deputy Commissioner Dr. Lester Crawford and Dr. Joseph Jasinski of IBM Life Sciences to give keynote presentations at 3rd Annual Biotech Industry Conference

Synoptics Opens New US Facility - To Provide Outstanding Sales and Service Support

Obesity Drugs Disappoint 

Early Results for MDX-CTLA4 are Promising 

Axokine for Type II Diabetics 

The Human Genome is Sequenced 

Remicade for Sciatica

Revmid Receives Another Fast Track Designation

Expert Comments on Antegren Potential

LymphoStat-B Advances

Capsulution NanoScience AG signs development co-operation with Dutch OctoPlus B.V.

Axokine for Type II Diabetics 

The Human Genome is Sequenced 

Remicade for Sciatica

Revmid Receives Another Fast Track Designation

Expert Comments on Antegren Potential

LymphoStat-B Advances

Capsulution NanoScience AG signs development co-operation with Dutch OctoPlus B.V.

Where Science and Art Meet Images Generated by Auto-Montage Shown at Prestigious Art Exhibition

BMD announces new ISO 9001 certification

Affymetrix at ESHG meeting - preview of new product

Synbiosis Names Don Whitley Dealer of the Year

OXFORD BIOMEDICA - COMPANY UPDATE AT AGM

Wong’s BioTech Stock Report - Bumps In the Road Genentech

Wong’s BioTech Stock Report - outlook on allergic asthma (“asthma”) therapeutics

bIoWISDOM APPOINTS INDUSTRY VETERAN AS DIRECTOR OF SALES AND BUSINESS DEVELOPMENT

Analysis Highlights Risks of Natrecor in Certain Clinical Circumstances 

Meta-Analysis Demonstrates Angiomax Benefit for Patients with Renal Impairment 

Novastan Plus ReoPro or Integrilin Promising for PCI Patients 

Campath for Multiple Sclerosis

Exanta for Stroke Prevention

Synthetic Bone Graft To Be Tested In Revision Hip Surgery

Axokine Results Are a Bit Slim

Profile of Tanox

Cambridge Healthcare & Biotech Ltd tonight announced the formation of a new consulting company

Picking Up the Trial

Inhaled Insulin for Smokers

SIRNA Drugs are Promising as Research Gains Traction 

Crestor To Enter the Competitive Statin Market in the U.K.

Zavesca NDA Amendment Submitted

Biotech Tracker News - BioMarin’s Aryplase Moves Toward Phase III 

Biotech Tracker News - Affinitak Down But Not Out 

Biotech Tracker News - Copaxone for Lou Gehrig Disease 

Biotech Tracker News - Learning from Betabloc Trials 

Biotech Stock Report - The April report provides an outlook on rheumatoid arthritis (RA) therapeutics. RA is considered an autoimmune disease

ALTANA Pharma obtains first license to atugen’s proprietary lipids

New Time Saving Feature for Gel Imaging Software Allows User to Rapidly Recreate their Settings at the Touch of a Button

Morphochem and Xenogen collaborate to develop novel drug candidates against bacterial biofilms

The Automation Partnership Introduces PicoTube™ for Sample Management at DDT Europe

Capsulution NanoScience AG acquires patents of former Aventis Research & Technologies

SWITCH Biotech appoints new Chief Development Officer for the future clinical development phases of trial substances

BioWisdom completes £2.5 million (€3.6 million) development capital financing

metaGen and RNAx Announce Target Validation Agreement

AMBION AND CENIX BIOSCIENCE PARTNER TO OFFER FIRST COMMERCIALLY-AVAILABLE HUMAN GENOME-WIDE siRNA LIBRARY

Bio-Rad's WorksBase™ 1.1 is the first fully integrated proteomic informatics software platform

New Criterion XT precast gels have up to a 12-month shelf life.

Bio-Rad's new 24 cm ReadyStrip IPG strips feature bar coding for high-throughput efficiency

North America’s most effective biotech/phama partnering forum - April 3-4, 2003, San Francisco, CA, USA

Cytomyx enters into Europe-wide distribution agreement with Clinomics Biosciences, Inc

Neurotech strengthens its position in ophthalmology through collaboration with INSERM and the Quinze-Vingts Hospital, Paris

Nonlinear Dynamics appoints new General Manager for Asia Pacific Rim region

Cambridge Antibody Technology Reports The Development Of Abthrax tm By Human Genome Sciences, Inc 

Biotech Tracker News - Study Highlights the Barriers to the Use of Genetic Susceptibility Testing 

Biotech Tracker News - Small Study Supports DX-88 Development 

Biotech Tracker News - Levitra Approved in Europe 

BIO-RAD CONFOCAL AND MULTI-PHOTON FRET MICROSCOPY IN LIVING CELLS

Biotech Tracker News - Phase III Pexelizumab Trial Enrolled 

Biotech Tracker News - Preos is Looking Good 

Biotech Tracker News - Zavesca Launched in the U.K. 

Biotech Tracker News - Crestor Launched in Holland 

Biotech Tracker News - FDA Committee Gives Green Light to Certain Gene Therapy Trials 

Biotech Tracker News - Lymphoma Risk for TNF Inhibitors 

Biotech Tracker News - Priority Review for Extended Arixtra Administration 

Biotech Tracker News - FDA Panel Recommends Further Study of TNF Inhibitor Safety 

Pfizer/Pharmacia: Moving the goalposts

Diabetes: time for a new regime?

Anticonvulsants: Pfizer's pregabalin to top success of Neurontin?

Syngene Software Upgraded for Multi-plexing Allows Seamless Overlaying of Separate Gel Images 

Multiple Myeloma: Increasing the therapeutic options

Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics

Rheumatoid Arthritis: Abbott looking for a greater share

Hormonal Cancers: Key drivers in a market of change

Pharmaceutical giants over-invest in promotion

Biotech Stock Report - Picking Up the Trail

MORPHOCHEM AND GBF SET UP COOPERATION AGREEMENT Tubulysin: new compounds against cancer

OXFORD BIOMEDICA PLC (LSE:OXB) PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2002

Innate Pharma strengthens management team

BioBridge Associates and biomaterials in Scotland

OXFORD BIOMEDICA OBTAINS APPROVAL FOR TROVAX® TO ENTER PHASE II TRIALS FOR COLORECTAL CANCER

November 2003 Archive

October 2003 Archive

September 2003 Archive

July/August 2003 Archive

June 2003 Archive

May 2003 Archive

March/April 2003 Archive

February 2003 Archive

January 2003 Archive

December Archive

November Archive

October Archive

September Archive

August Archive

July Archive

June Archive

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.